Management of Menopausal Symptoms

Size: px
Start display at page:

Download "Management of Menopausal Symptoms"

Transcription

1 Management of Menopausal Symptoms Tammie Koehler DO, FACOG 1 Menopause Permanent cessation of menstruation that occurs after the loss of ovarian activity Determined to have occurred after 1 full year of no menstrual cycles Median age in US is 51 years 2 1

2 Menopausal transition (perimenopause in past) Fluctuations in hormone levels due to ovarian function slow down Serum levels of estradiol, progesterone decrease, FSH increases Results in physiological changes and clinical symptoms Most common are vasomotor and vaginal symptoms 3 Vasomotor symptoms Sudden sensation of extreme heat in upper body especially face, neck and chest. Last typically 1-5 minutes Associated with perspiration, flushing, chills, clamminess, anxiety and occasionally palpitations May interfere with sleep and cause chronic sleep disruption Episodes vary in frequency and duration 87% of women experience these on daily basis, and approximately 33% experience more than 10 episodes a day May persist longer than previous estimate of 1 year after cessation of periods, published reports indicate overall duration remains unclear. Median durations of years 4 2

3 Pathophysiology of Hot Flashes Not fully understood but related to multiple factors Changes in reproductive hormones, decrease in estrogen and increase in FSH, play a critical role however they are not solely responsible as symptoms vary greatly among women in the menopausal transition Thermoregulatory zone narrows and becomes more sensitive to subtle changes in body temperature Estrogen widens this zone Serotonergic, noradrenergic, opioid, adrenal and autonomic systems also play a role 5 Risk Factors for Vasomotor symptoms Racial and ethnic differences have been shown in observational studies The Study of Women s Health Across the Nation assessed 14,906 women age with diverse ethnic backgrounds African Americans reported most symptoms Asian women the fewest Making consideration of diet of high soy may account for the differences Differing cross-cultural perceptions and reporting 6 3

4 Vaginal Symptoms Atrophy-direct consequence of the hypoestrogenic state Results in anatomic and physiologic changes in the genitoutinary tract Loss of superficial epithelial cells causing thinning of tissue Loss of vaginal rugae Loss of elasticity with narrowing and shortening of the vagina Vaginal ph becomes more alkaline, alters the normal flora resulting in increased risk of urogenital infections. Vaginal secretions decrease Loss of subcutaneous fat in labia majora Narrowing of the introitus, fusions of the labia minora and shrinking of clitoral prepuce and urethra 7 Hormonal Treatment Most effective estrogen or combination HRT (at standard doses) shows 75% reduction in weekly hot flush frequency and severity according to Cochran meta-analysis of 24 randomized controlled trials that included 3,329 participants. There is no Data to support progestin only, testosterone or compounded bioidentical hormones Goal of treatment is the lowest effective dose for the shortest period of time to control symptoms 8 4

5 Risks Risk-benefit ratio must be considered and the treatment individualized with a end goal Thromboembolic disease and breast cancer WHI study reported slightly increased risk of breast cancer, coronary heart disease, stroke and venous thromboembolic events but a decrease in risk of fracture and colon cancer after an average of 5 years treatment. In estrogen only arm there was an increased risk of thromboembolic events but not an increased risk of cardiovascular events or breast cancer WHI was aimed at assessing HRT for primary coronary heart disease prevention in women aged Most past the menopausal transition. 9 Testosterone in combination with HRT Cochran meta-analysis of 35 trials with 4,768 participants shows no significant benefit and potential adverse effects: Lipid parameters Clitoromegaly Hirsutism Acne The same study suggests that the addition improved sexual function scores in postmenopausal women 10 5

6 Bioidentical Hormones Plant-derived and chemically similar or structurally identical to those produced in the body Micronized progesterone and estradiol (regulated by FDA) Compounded preparations No rigorous clinical testing for safety or efficacy. Concern for potency, purity, and quality. Consideration for under or over dosage due to variable bioavailability and bioactivity 11 Non-Hormonal Medications Selective serotonin reuptake inhibitors (SSRI) and selective serotonin-norepinephrin reuptake inhibitors (SSNRI). Randomized controlled trial of 365 women found a 62% reduction vs 41% placebo for moderate to severe hot flashes with treatment effect maintained for 1year Meta-analysis demonstrated significant reduction compared to placebo. Paroxetine(7.5mg/d) is the only non-hormonal therapy approved by the FDA for treatment of vasomotor symptoms. Adverse effects included nausea, dizziness, dry mouth, nervousness, constipation, somnolence, sweating and sexual dysfunction. These generally resolved with time or dose adjustment. 12 6

7 Clonidine Centrally acting alpha 2-agonist. (not FDA approved for this indication) Systematic review and meta-analysis reported a small benefit with clonidine 0.1mg/d compared to placebo Adverse effects were dry mouth, insomnia and drowsiness, at this dose blood pressure was not adversely affected 13 Gabapentin A gamma amniobutyric acid analog Not FDA approved for this indication Randomized control trial of gabapentin 900mg/d demonstrated a 45% reduction in frequency and a 54% reduction in severity. Adverse effects include dizziness, somnolence and peripheral edema. 14 7

8 Phytoestrogens Plant derived substances with estrogenic biologic activity Isoflavones, genistein and daidzein, found in soy porducts and red clover. Original interest stemmed from observation that the Asian women experience fewer vasomotor symptoms and their diets are rich in soy based products. Studies are limited by small sample size. A Cochran metaanalysis or 30 placebo controlled trials of high levels of phytoestrogens for treatment of vasomotor symptoms and found no significant difference from placebo 15 Herbal remedies Chinese herbal medicine, Black cohosh, Ginseng, St. John s wort and Ginkgo. Dong Quai, limited data to support safety and effectiveness, one small RCT shows no difference from placebo. Adverse effects: photosensitivity and increased risk bleeding in patients on warfarin One study Chinese herbal medicine plus acupuncture was found to be as effective as HT in relieving symptoms Black Cohosh- data is conflicting regarding efficacy and safety due to limited study quality. Reports of liver toxicity have been made. Studies have not shown that herbs as listed either alone or in combination are superior to placebo. Vitamins- limited data on the effectiveness of vitamins for treatment. One study shows marginal reduction, (one less hot flush/day) with vitamin E 800IU/d 16 8

9 Alternative Techniques Acupuncture- meta-analysis of 6 studies showed no benefit over placebo Reflexology- no significant reduction in symptoms compared to non-specific foot massage Preliminary data suggest the local injection of anesthetic into the stellate ganglion may reduce vasomotor symptoms in women with contraindications to HRT. 17 Management of vaginal symptoms Estrogen therapy All low dose systemic estrogen formulations are FDA-approved. Oral conjugated estrogen as low as 0.3mg/d and transdermal estradiol of 12.5mcg/d have demonstrated improvement Local vaginal estradiol or conjugated equine estrogen in the form of cream, ring and tablet are effective in treatment. Typical dosage is daily for 1-2 weeks as induction therapy and then low dose 2-3 times weekly for maintenance dosage. Systemic absorption of vaginal estrogen has been documented using a daily low-dose preparation with 25mcg. Cochran meta-analysis of 19 trials with 4,162 women found no association with increased risk of endometrial hyperplasia compared to placebo. 18 9

10 Estrogen Agonists and Antagonists Synthetic compounds that selectively stimulate or inhibit the estrogen receptors of different target tissues. Raloxifene and tamoxifen are not effective for the treatment of menopausal vaginal symptoms. Ospemifene is a novel estrogen agonist/antoagonist that improves vaginal atrophy without stimulating the endometrium. A study of 826 postmenopausal women randomized to 30 mg/d vs 60 mg/d. Showed that 60mg/d was effective for improving vulvovaginal atrophy. Adverse effects: hot flushes, vaginal discharge, muscle spasms, genital discharge and excessive sweating 19 Non-hormonal therapies Vaginal lubricants- water or silicone based, are intended to be used to relieve friction and dyspareunia secondary to vaginal dryness during intercourse. Vaginal moisturizers are intended to trap moisture and provide long term relief of vaginal dryness Prospective studies have demonstrated that moisturizers improve vaginal dryness, ph balance and elasticity and reduce vaginal itching, irritation and dyspareunia

11 What about breast cancer patients Non hormonal pharmacologic treatments, lifestyle alterations and alternative or complimentary therapy. SSRI s, SSNRI s show some decrease in severity and frequency of vasomotor symptoms. In a number of RCT s significant reduction in hot flushes among breast cancer survivors using venlafaxine was seen. The optimal balance between effectiveness and adverse effects seems to be 75mg po daily. Other trials have evaluated low doses of paroxetine, fluoxetine and citalopram with reduction of symptoms. Short term use of hormonal methods may be considered in women with severe or refractory symptoms following appropriate counseling with their oncologists and about potential risks. 21 Bibliography ACOG-practice bulletin #141, January 2014 Cochran data base systemic reviews 2004, Issue 4. Postmenopausal estrogen/progesterone Interventions Trial. Obstet Gynecol 1998;92: Writing Group for the Women s Health Initiative Investigators. JAMA 2002;288: Women s Health InitiativeSteering Committee. JAMA 2004;291: ACOG Committee Opinion Number 532 Climacteric 2009;12:16-25 Obstet Gynecol practice bulletin no 126/ 2012 Questions???? 22 11

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories

Learning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen

More information

Menopause and Post Gynecological Reproductive Care

Menopause and Post Gynecological Reproductive Care Menopause and Post Gynecological Reproductive Care Nguyet-Cam Vu Lam, MD, FAAFP Associate Program Director St. Luke s Family Medicine Residency 1 Disclosure Dr. Nguyet-Cam Vu Lam has no conflict of interest,

More information

OVERVIEW OF MENOPAUSE

OVERVIEW OF MENOPAUSE OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause

More information

Managing menopause in Primary Care and recent advances in HRT

Managing menopause in Primary Care and recent advances in HRT Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG PG Cert. Advanced Gynaecology Endoscopy Consultant Gynaecologist Heart of England NHS Foundation Trust Spire Parkway

More information

Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School

Women s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help

More information

MENOPAUSAL HORMONE THERAPY 2016

MENOPAUSAL HORMONE THERAPY 2016 MENOPAUSAL HORMONE THERAPY 2016 Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA NICE provides the National Health Service advice on effective, good value healthcare.

More information

Managing menopause in Primary Care and recent advances in HRT

Managing menopause in Primary Care and recent advances in HRT Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG Consultant Gynaecologist Heart of England NHS Foundation Trust rajsaha1@yahoo.co.uk Content of today s talk Aims

More information

WHI Estrogen--Progestin vs. Placebo (Women with intact uterus)

WHI Estrogen--Progestin vs. Placebo (Women with intact uterus) HORMONE REPLACEMENT THERAPY In the historical period it was commonly held that estrogen had two principal benefits to postmenopausal women: 1) To alleviate the constitutional symptoms related to the climacteric

More information

Flashpoint: Regulating Your Body s Temperature. Presented by: Shari M. Lawson, MD MBA Date Presented: November 1,

Flashpoint: Regulating Your Body s Temperature. Presented by: Shari M. Lawson, MD MBA Date Presented: November 1, Flashpoint: Regulating Your Body s Temperature Presented by: Shari M. Lawson, MD MBA Date Presented: November 1, 2014 1 Disclosures None 2 Objectives Today s discussion will cover How body temperature

More information

Management of Menopausal Symptoms in Patients with Breast Cancer. Mike Dixon Edinburgh Breast Unit

Management of Menopausal Symptoms in Patients with Breast Cancer. Mike Dixon Edinburgh Breast Unit Management of Menopausal Symptoms in Patients with Breast Cancer Mike Dixon Edinburgh Breast Unit Menopausal symptoms have a major impact on Quality of Life Variety of Symptoms associated with the Menopause

More information

What is the menopause?

What is the menopause? Information for you Alternatives to hormone replacement therapy for symptoms of the menopause Published in December 2011 This information is for you if you are considering alternatives to hormone replacement

More information

Case Presentation. Learning Objectives. Case Presentation. Case Presentation

Case Presentation. Learning Objectives. Case Presentation. Case Presentation Learning Objectives To apply up to date information about the natural history of menopause to improve the care of individual women To counsel women about the risks and benefits of systemic hormone therapy

More information

Menopausal Management: What Has Changed?

Menopausal Management: What Has Changed? Menopausal Management: What Has Changed? Julia V. Johnson, M.D. Professor and Chair, OB/GYN University of Massachusetts Medical School UMass Memorial Medical Center Conflicts of Interest None Learning

More information

Menopause: diagnosis and management NICE guideline NG23. Published November 2015

Menopause: diagnosis and management NICE guideline NG23. Published November 2015 Menopause: diagnosis and management NICE guideline NG23 Published November 2015 1 Full title: Menopause : diagnosis and management Available at: http://www.nice.org.uk/guidance/ng23 Guideline published

More information

MENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?

MENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE? MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early

More information

Navigating the Change: Leading Patients Through Menopause

Navigating the Change: Leading Patients Through Menopause 4:30pm - 5:30pm: Breakout 5 - Women s Health Option A: Navigating the Change: Leading Patients Through Menopause ACPE UAN 0107-0000-10-025-L01-P 0.1 CEU/1.0 Hr. Activity Type: Application-Based Program

More information

Gary Elkins, PhD., ABPP

Gary Elkins, PhD., ABPP Gary Elkins, PhD., ABPP *What are Hot Flashes? *Hormone Replacement Therapy *Alternate Treatment Options *Clinical Hypnosis? *Methods *Preliminary Results *Conclusions & Future Directions *Over 66% of

More information

22/09/2014. Menopause Management. Menopause. Menopause symptoms

22/09/2014. Menopause Management. Menopause. Menopause symptoms Menopause Management Dr Sonia Davison Jean Hailes for Women s Health Menopause Time of last menstrual period - average age 51 Premature Menopause: occurs before age 40 Perimenopause (menopause transition):

More information

Menopause Symptoms and Management: After Breast Cancer

Menopause Symptoms and Management: After Breast Cancer Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a

More information

2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK

2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK 2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail

More information

Menopause and HRT. John Smiddy and Alistair Ledsam

Menopause and HRT. John Smiddy and Alistair Ledsam Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation

More information

Menopause & HRT. Rosie & Alex. Image:

Menopause & HRT. Rosie & Alex. Image: Menopause & HRT Rosie & Alex Image: http://www.keepcalm-o-matic.co.uk/ Menopause The permanent cessation of menstruation for 12 months When does it happen? Average age 51 Image: Nature Medicine - 12, 612-613

More information

What s New in Menopause Management. Objectives

What s New in Menopause Management. Objectives What s New in Menopause Management Leslee L. Subak, MD Professor of Obstetrics, Gynecology & Reproductive Science University of California, San Francisco Objectives Define the menopause transition Review

More information

OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.

OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,

More information

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College

HRT in Perimenopausal Women. Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College HRT in Perimenopausal Women Dr. Rubina Yasmin Asst. Prof. Medicine Dhaka Dental College 1 This is the Change But the CHANGE is not a disease 2 Introduction With a marked increase in longevity, women now

More information

Non hormonal medical treatment of vasomotor symptoms

Non hormonal medical treatment of vasomotor symptoms Non hormonal medical treatment of vasomotor symptoms Caroline Antoine Menopause Clinic Department of Gynaecology and Obstetrics CHU Saint-Pierre Belgian Menopause Society Symposium November 14, 2015 No

More information

Menopause - a summary of management

Menopause - a summary of management Page 1 of 5 Menopause - a summary of management Original article by: May Su Resources Menopause treatment algorithm The Jean Hales Foundation for women's heath. Menopause, a treatment algorithm. (Australian

More information

By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University

By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University Cessation of menstruation as a result of the aging process of or surgical removal of the ovaries; change

More information

A Practitioner s Toolkit for the Management of the Menopause

A Practitioner s Toolkit for the Management of the Menopause Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash

More information

HRT & Menopause Where Do We Stand Now?

HRT & Menopause Where Do We Stand Now? HRT & Menopause Where Do We Stand Now? Mrs. SY Hussain Consultant Gynaecologist The Holly Private Hospital Spire Roding Hospital The Wellington Hospital Discussion Points Discuss Recommendations made by

More information

Menopause & HRT. Matt McKenna Elliot Davis

Menopause & HRT. Matt McKenna Elliot Davis Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea

More information

New Treatments for Vaginal Health. Sarah Azad, MD El Camino Women s Medical Group

New Treatments for Vaginal Health. Sarah Azad, MD El Camino Women s Medical Group New Treatments for Vaginal Health There s Hope Sarah Azad, MD El Camino Women s Medical Group The Genitrourinary Syndrome of Menopause (GSM) Problems with genital health secondary to the changes that occur

More information

11/15/2017. Update on HRT. Highgate Private Hospital (Barnet Hospital) Women s Health. Menopause

11/15/2017. Update on HRT. Highgate Private Hospital (Barnet Hospital) Women s Health. Menopause Update on HRT Miss Moneli Golara Consultant Obstetrician and Gynaecologist MBBS, FRCOG Highgate Private Hospital (Barnet Hospital) E: lauren@medicaladministration.co.uk Women s Health Life expectancy of

More information

What's New in Menopause Management

What's New in Menopause Management Annual Review of Family Medicine December 10, 2015 San Francisco, CA What's New in Menopause Management Michael Policar, MD, MPH Clinical Professor of Ob, Gyn, and Repro Sciences UCSF School of Medicine

More information

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018

Post-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018 Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma

More information

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology

CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology CASE 4- Toy et al. CASE FILES: Obstetrics & Gynecology A 49-year-old woman complains of irregular menses over the past 6 months, feelings of inadequacy, vaginal dryness, difficulty sleeping, and episodes

More information

Menopause and HIV. Together, we can change the course of the HIV epidemic one woman at a time.

Menopause and HIV. Together, we can change the course of the HIV epidemic one woman at a time. Menopause and HIV Together, we can change the course of the HIV epidemic one woman at a time. #onewomanatatime #thewellproject What Is Menopause? Menopause: Point in time when a woman's menstrual periods

More information

Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD

Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD JoAnn V. Pinkerton, MD Professor of Obstetrics and Gynecology Director,

More information

Menopause management NICE Implementation

Menopause management NICE Implementation Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not

More information

NICE guideline Published: 12 November 2015 nice.org.uk/guidance/ng23

NICE guideline Published: 12 November 2015 nice.org.uk/guidance/ng23 Menopause: diagnosis and management NICE guideline Published: 12 November 2015 nice.org.uk/guidance/ng23 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List

Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Note: Commonly prescribed medication. Literature question Is estrogen effective and safe? Are conjugated estrogens effective and

More information

Management of Perimenopausal symptoms

Management of Perimenopausal symptoms Management of Perimenopausal symptoms Serge Rozenberg CHU St Pierre Université libre de Bruxelles Belgium serge_rozenberg@stpierre-bru.be serge.rozenberg@skynet.be Conflict of interest & Disclosure Conflicts

More information

Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women

Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms in Postmenopausal Women Cronicon OPEN ACCESS PHARMACEUTICAL SCIENCE Research Article The Treatment with Hormone Replacement Therapy and Phytoestrogens and The Evolution of Urogenital Symptoms Bungau S 1, Tit DM 1 *, Fodor K 1

More information

Year: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy

Year: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy Year: 2013 - Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy By: Dr David W Sturdee, Immediate past President International Menopause Society and Hon Consultant Gynaecologist, Solihull

More information

Acne rosacea is a skin condition that causes facial flushing and can co-exist with menopausal flushing.

Acne rosacea is a skin condition that causes facial flushing and can co-exist with menopausal flushing. MANAGING HOT FLUSHES In Western societies, the most common menopause symptom is the hot flush. This typically begins as a feeling of heat in the chest or upper body which then spreads all over the body,

More information

This information can be found by going to Hot Flashes

This information can be found by going to   Hot Flashes Winsor Pilates - Official Site Reach physical and mental health while sculpting your... www.winsorpilates.com ML Speakers Group -Women's Health Today Book an exciting speaker to make your event special.

More information

UPDATE: Women s Health Issues

UPDATE: Women s Health Issues UPDATE: Women s Health Issues Renee B. Alexis, MD, MBA, MPH, FACOG Associate Professor Department of OBGYN Kiran C. Patel College of Osteopathic Medicine Disclosure of Conflicts of Interest I have no financial

More information

Authors' objectives To evaluate the efficacy of complementary and alternative therapies for the management of menopausal symptoms.

Authors' objectives To evaluate the efficacy of complementary and alternative therapies for the management of menopausal symptoms. Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review Nedrow A, Miller J, Walker M, Nygren P, Huffman L H, Nelson H D CRD summary This review

More information

Hormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare

Hormones friend or foe? Undertreatment and quality of life. No conflicts of interest to declare Hormones friend or foe? Undertreatment and quality of life Anette Tønnes Pedersen MD, Ph.D. Consultant, Associate professor Dept. Of Gynecology / Fertility Clinic Rigshospitalet No conflicts of interest

More information

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition

Menopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists

More information

Before you prescribe

Before you prescribe Initiating hormone replacement therapy (HRT) / menopausal hormone therapy (MHT) Dr Sonia Davison Jean Hailes Consultant Endocrinologist Before you prescribe Ensure there are no contraindications to HRT/MHT

More information

Menopause Matters. Equity Office Staff Seminar 14 November 2018

Menopause Matters. Equity Office Staff Seminar 14 November 2018 Menopause Matters Equity Office Staff Seminar 14 November 2018 1 What to expect at menopause How to manage symptoms Support at work Dr Janice Brown Medical lead, The University of Auckland NZ representative,

More information

GERIATRICS: definitions

GERIATRICS: definitions Caring For The Modern Menopausal Woman in 2016: An Update on Women s Health In the Geriatric Population David J Boes, DO, FACOOG MSU-COM May 2016 What defines the geriatric population???? GERIATRICS: definitions

More information

North American Menopause Society (NAMS)

North American Menopause Society (NAMS) North American Menopause Society (NAMS) 2012 Hormone Therapy Position Statement Cynthia B. Evans, MD Assistant Professor-Clinical Department of Obstetrics and Gynecology The Ohio State University College

More information

This includes bone loss, endometrial cancer, and vasomotor symptoms.

This includes bone loss, endometrial cancer, and vasomotor symptoms. Hello and welcome. My name is Chad Barnett. I m a Clinical Pharmacy Specialist in the Division of Pharmacy at the University of Texas, MD Anderson Cancer Center and I m very pleased today to be able to

More information

Virtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11

Virtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11 Virtual Mentor Ethics Journal of the American Medical Association November 2005, Volume 7, Number 11 Clinical Pearl Post Women's Health Initiative Menopausal Women and Hormone Therapy by JoAnn V. Pinkerton,

More information

Guidelines for Menopause Management

Guidelines for Menopause Management Guidelines for Menopause Management Judith M.E. Walsh, MD, MPH Professor of Medicine UCSF Women s Health Center of Excellence Conflicts of Interest: None Overview Natural history of menopause Hormone therapy:

More information

Pearls for Menopause Management: I m ready: now what?

Pearls for Menopause Management: I m ready: now what? Pearls for Menopause Management: I m ready: now what? Friday November 13, 2015 Susan Goldstein MD CCFP FCFP NCMP Assistant Professor Department of Family and Community Medicine University of Toronto Menarche

More information

Hormone therapy. Where are we now? Menopause. Menopause symptoms. Background. Objective. Discussion. Keywords: menopause; hormone therapy

Hormone therapy. Where are we now? Menopause. Menopause symptoms. Background. Objective. Discussion. Keywords: menopause; hormone therapy Menopause Helena J Teede Amanda Vincent Hormone therapy Where are we now? Background Menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity. The characteristic

More information

Hot flushes in breast cancer patients

Hot flushes in breast cancer patients Critical Reviews in Oncology/Hematology 57 (2006) 63 77 Hot flushes in breast cancer patients Constantijne H. Mom a, Ciska Buijs a, Pax H.B. Willemse a, Marian J.E. Mourits b, Elisabeth G.E. de Vries a,

More information

Financial Disclosures

Financial Disclosures Common Cases and Conundrums in Menopause care Dr. Kerstin Gustafson, MD, FRCSC Financial Disclosures Dr. Kerstin Gustafson, MD, FRCSC, NCMP Speaker fees: Amgen Bayer Merck Novartis Novo-Nordisk Warner-Chilcott

More information

Primary Care of the Breast Cancer Survivor. Case Presentation. Case Presentation (cont) Case Presentation (cont) Breast Cancer

Primary Care of the Breast Cancer Survivor. Case Presentation. Case Presentation (cont) Case Presentation (cont) Breast Cancer Primary Care of the Breast Cancer Survivor Janet P. Pregler, MD Professor of Clinical Medicine Director, Iris Cantor UCLA Women s Health Center Case Presentation B.C. is a 58 year-old African American

More information

Citation for published version (APA): Buijs, C. (2008). Long-term side effects of adjuvant breast cancer treatment s.n.

Citation for published version (APA): Buijs, C. (2008). Long-term side effects of adjuvant breast cancer treatment s.n. University of Groningen Long-term side effects of adjuvant breast cancer treatment Buijs, Ciska IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite

More information

What in the HRT do we do now? Selecting, managing and maintaining patients on hormone therapy.

What in the HRT do we do now? Selecting, managing and maintaining patients on hormone therapy. What in the HRT do we do now? Selecting, managing and maintaining patients on hormone therapy. KELLIE FLOOD-SHAFFER, MD, FACOG ASSOCIATE PROFESSOR UNTHSC-DEPARTMENT OF OB/GYN . I have no conflicts of interest

More information

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation

The 6 th Scientific Meeting of the Asia Pacific Menopause Federation Abnormal uterine bleeding in the perimenopause Perimenopausal menstrual problems are among the most common causes for family practitioner and specialist referral. Often it is due to the hormone changes

More information

HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D

HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D All of the hormones in your body are designed to work together. This is God s plan. Therefore, if one is altered, or deficient, it will affect the actions

More information

WHI Form 55 Estrogen-Alone Survey Ver. 2

WHI Form 55 Estrogen-Alone Survey Ver. 2 Date Received: - - (M/D/Y) Reviewed By: - Affix label here- Clinical Center/ID: - - First Name M.I. Last Name Contact Type: Phone Visit Type: Form Administration: Mail Semi-Annual # Self 3 Visit 3 Annual

More information

Effects of menopause and hormone replacement therapy (HRT) on quality of life of women

Effects of menopause and hormone replacement therapy (HRT) on quality of life of women Effects of menopause and hormone replacement therapy (HRT) on quality of life of women MD. Nguyen Thi Ngoc Phuong President of the Ho Chi Minh City Reproductive Endocrinology and Infertility Association

More information

Appendix: Reference Table of HT Brand Names

Appendix: Reference Table of HT Brand Names Appendix: Reference Table of HT Brand Names This is a full reference table in alphabetical order, of Brand Name drugs used in HT. It is the basis for prescription advice throughout this handbook. Drug

More information

Overview: Identifying Candidates and Tailoring Treatment. Disclosures 10/6/2014. Vasomotor Symptoms. VMS in Postmenopausal Women

Overview: Identifying Candidates and Tailoring Treatment. Disclosures 10/6/2014. Vasomotor Symptoms. VMS in Postmenopausal Women Overview: Identifying Candidates and Tailoring Treatment Risa Kagan, MD, FACOG, CCD, NCMP Clinical Professor, Department of Ob-Gyn, UCSF East Bay Physicians Medical Group Sutter Foundation, Berkeley, CA

More information

Venous thromboembolism 5 years of use *p-value <.05. Net bad events +2.0* +0.6

Venous thromboembolism 5 years of use *p-value <.05. Net bad events +2.0* +0.6 Management of Menopause: Should New Data Change Our Practice? Mary S. Beattie, MD, MAS Associate Professor of Medicine UCSF Women s Health, Primary Care Director of Clinical Research, UCSF Cancer Risk

More information

Management of Menopausal Symptoms

Management of Menopausal Symptoms Clinical Expert Series Management of Menopausal Symptoms Andrew M. Kaunitz, MD, and JoAnn E. Manson, MD, DrPH Downloaded from https://journals.lww.com/greenjournal by BhDMf5ePHKav1zEoum1tQfN4a+kJLhEZgbsIHo4XMi0hCywCX1AWnYQp/IlQrHD3K8IvHCABgh/bIG0s8pUeOW5ZlL84rYIWpMvpbO4KRoE=

More information

Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene)

Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) EMA/679870/2014 Summary of the risk management plan (RMP) for Duavive (conjugated oestrogens / bazedoxifene) This is a summary of the risk management plan (RMP) for Duavive, which details the measures

More information

New Terminology Old Problem!

New Terminology Old Problem! New Terminology Old Problem! Dr. Chevelta A. Smith Adjunct Professor of LECOM - OB/Gyn March 3, 2018 Discuss the reason behind the development of this new terminology Review the Old Terminology for which

More information

Complementary Therapy. Hormonal Treatment and Alternatives in Breast Cancer Survivors

Complementary Therapy. Hormonal Treatment and Alternatives in Breast Cancer Survivors Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Complementary Therapy Hormonal Treatment and Alternatives in Breast Cancer Survivors Survivorship Complementary Therapy Hormonal

More information

Practical recommendations for hormone replacement therapy in the peri- and postmenopause

Practical recommendations for hormone replacement therapy in the peri- and postmenopause CLIMACTERIC 2004;7:in press Practical recommendations for hormone replacement therapy in the peri- and postmenopause Recommendations from an Expert Workshop, February 2004 Henry Burger, Australia; David

More information

OBSTETRICS & GYNECOLOGY

OBSTETRICS & GYNECOLOGY AUGUST 2011 NORLAND AVENUE PHARMACY PRESCRIPTION COMPOUNDING N ORLANDA VENUEP HARMACY. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: BHRT for Menopause

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Index Note: Page numbers of article titles are in boldface type. A Abdominal myomectomy in leiomyoma management, 77 Abnormal uterine bleeding (AUB) described, 103 105 normal menstrual bleeding vs., 104

More information

Treatment of Mood Disorders in Midlife Women

Treatment of Mood Disorders in Midlife Women Treatment of Mood Disorders in Women KAY ROUSSOS-ROSS, MD UNIVERSITY OF FLORIDA DEPARTMENTS OF OBGYN AND PSYCHIATRY Disclosures I HAVE NO DISCLOSURES Objectives UNDERSTAND INCIDENCE OF MOOD DISORDERS IN

More information

Quality of Life. Local Therapy of UG Atrophy. Key Message #1 24/05/2018. Perception of Fears/Problems at Menopause

Quality of Life. Local Therapy of UG Atrophy. Key Message #1 24/05/2018. Perception of Fears/Problems at Menopause Disclosure Menopause Webinar May 24, 2018 Gillian Graves Obs Gyn Dalhousie University Retired No Advisory Boards or other industry relations Guidelines Oversight Committee SOGC Royal College Subspecialty

More information

HRT. Responding to questions about. The Women s Health Initiative (WHI) is a large, CME Workshop. associated with combined

HRT. Responding to questions about. The Women s Health Initiative (WHI) is a large, CME Workshop. associated with combined CME Workshop Responding to questions about HRT By Margaret Burnett, MD, BA(Hon), MA, CCFP, FRCPC The Women s Health Initiative (WHI) is a large, prospective, placebo-controlled trial sponsored by the National

More information

Presentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy

Presentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy Presentation to the Clinical Utility of Treating Patients with Compounded Bioidentical Hormone Therapy March 5, 2019 Nese Yuksel, BScPharm, PharmD, FCSHP, NCMP Professor Faculty of Pharmacy and Pharmaceutical

More information

OBSTETRICS & GYNECOLOGY

OBSTETRICS & GYNECOLOGY JANUARY 2012 COMPOUNDING PHARMACY SOLUTIONS PRESCRIPTION COMPOUNDING WWW.CPSRXS. COM We customize individual prescriptions for the specific needs of our patients. INSIDE THIS ISSUE: Female Sexual Arousal

More information

Interventions to Address Sexual Problems in People with Cancer

Interventions to Address Sexual Problems in People with Cancer A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Interventions to Address Sexual Problems in People with Cancer L. Barbera, C. Zwaal, D. Elterman, K. McPherson,

More information

The Estrogen Question

The Estrogen Question The Estrogen Question Hormone Therapy still offers the best relief for menopausal symptoms. Is it right for you? When 49-year-old Lee Ann Dodson heard the news that the Women's Health Initiative (WHI)

More information

Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor

Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Thrombosis and Women s Health Risk factors, contraceptive pill, HRT and your doctor Dr Matthew Fay GP Principal The Willows Medical Practice- Queensbury GPwSI and Co-Founder Westcliffe Cardiology Service

More information

Imvexxy (estradiol) NEW PRODUCT SLIDESHOW

Imvexxy (estradiol) NEW PRODUCT SLIDESHOW Imvexxy (estradiol) NEW PRODUCT SLIDESHOW Introduction Brand name: Imvexxy Generic name: Estradiol Pharmacological class: Estrogen Strength and Formulation: 4mcg, 10mcg; vaginal inserts Manufacturer: TherapeuticsMD,

More information

Is Extract ERr731 from the Rheum Rhaponticum Effective in Relieving Menopausal Symptoms in Women Aged 45 to 55 Years of Age?

Is Extract ERr731 from the Rheum Rhaponticum Effective in Relieving Menopausal Symptoms in Women Aged 45 to 55 Years of Age? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2011 Is Extract ERr731 from the Rheum Rhaponticum

More information

Living with an Induced Menopause

Living with an Induced Menopause Living with an Induced Menopause Dr Jenifer Sassarini Clinical Lecturer Obstetrics and Gynaecology University of Glasgow 2 February 2017 70% of women in UK living with breast cancer have hot flushes 1/3

More information

Traditional Chinese Medicine (TCM) in the Management of Menopausal Symptoms/Conditions

Traditional Chinese Medicine (TCM) in the Management of Menopausal Symptoms/Conditions Introduction www.womenshealthclinic.co.uk Traditional Chinese Medicine (TCM) in the Management of Menopausal Symptoms/Conditions XY Zhang, PhD MD Women s Health Clinic, London, UK Email: xzhang@womenshealthclinic.co.uk

More information

MENOPAUSE. Women in Midlife: Menopause & Osteoporosis. Outline for Menopause. STRAW Stages of the Menopausal Transition-NAMS, /29/2012

MENOPAUSE. Women in Midlife: Menopause & Osteoporosis. Outline for Menopause. STRAW Stages of the Menopausal Transition-NAMS, /29/2012 Women in Midlife: Menopause & Osteoporosis Lisa Ward, MD, MScPH, MS UCSF CME Conference March 23rd, 2012 MENOPAUSE Outline for Menopause Definitions Summary of the Evidence Current Guidelines Management

More information

AusPharm CE Hormone therapy 23/09/10. Hormone therapy

AusPharm CE Hormone therapy 23/09/10. Hormone therapy Hormone therapy Learning objectives: Assess options to address quality of life and health concerns of menopausal women Outline indications for hormone therapy Counsel women on the risks and benefits of

More information

Drug Class Review on Estrogen for Treatment of Menopausal Symptoms and Prevention of Low Bone Density & Fractures. Final Report

Drug Class Review on Estrogen for Treatment of Menopausal Symptoms and Prevention of Low Bone Density & Fractures. Final Report Drug Class Review on Estrogen for Treatment of Menopausal Symptoms and Prevention of Low Bone Density & Fractures Final Report Heidi D. Nelson, MD, MPH Peggy Nygren, MA Benjamin K. S. Chan, MS Produced

More information

MENOPAUSE AN UPDATE ON THE NICE GUIDELINES What it means for us

MENOPAUSE AN UPDATE ON THE NICE GUIDELINES What it means for us MENOPAUSE AN UPDATE ON THE NICE GUIDELINES What it means for us NAPS STUDY DAY ON WOMEN S HEALTH 2017 Joan Pitkin BSc FRCS FRCOG Menopause Clinical & Research Unit Northwick Park & St Marks Hosp. London

More information

Bioidentical Hormones: Just the Facts

Bioidentical Hormones: Just the Facts Bioidentical Hormones: Just the Facts Melissa McNeil, MD, MPH Professor of Medicine and Obstetrics, Gynecology and Reproductive Sciences Chief, Section of Women s Health University of Pittsburgh Disclosures!

More information

5. Summary of Data Reported and Evaluation

5. Summary of Data Reported and Evaluation 326 5. Summary of Data Reported and Evaluation 5.1 Exposure data Combined estrogen progestogen menopausal therapy involves the co-administration of an estrogen and a progestogen to peri- or postmenopausal

More information

Does Black Cohosh Improve Anxiety/Depression Symptoms in Women Who Are Postmenopausal?

Does Black Cohosh Improve Anxiety/Depression Symptoms in Women Who Are Postmenopausal? Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 2015 Does Black Cohosh Improve Anxiety/Depression

More information

While the average age of menopause in North America is 52, some women may go through

While the average age of menopause in North America is 52, some women may go through Overview Symptoms Causes Prescription Health Tips Historically, menopause was treated as a disease due to its associated symptoms. Today, it is understood menopause is a natural transition in a woman s

More information

Applying Best Evidence to Menopause Management MENOPAUSE IS NOT A DISEASE. Overview. Feminine Forever. Page 1

Applying Best Evidence to Menopause Management MENOPAUSE IS NOT A DISEASE. Overview. Feminine Forever. Page 1 Applying Best Evidence to Menopause Management Judith Walsh, MD, MPH Division of General Internal Medicine Women s Health Center of Excellence UCSF Overview Natural history of menopause Hormone therapy:

More information